National Coverage Analysis (NCA)

Dermal injections for the treatment of facial lipodystrophy syndrome (FLS)

CAG-00412N

Expand All | Collapse All

Contacts

Sarah Fulton
sarah.fulton@cms.hhs.gov
410-786-2749
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Dermal injections for the treatment of facial lipodystrophy syndrome (FLS) CAG-00412N You are here